More Articles

While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
February 14, 2019 | Heart Failure

Heart failure (HF)—both symptomatic and asymptomatic—is associated with an up to 10 percent increased risk of 90-day postoperative mortality in patients undergoing noncardiac surgery, according to a study published Feb. 12 in the…

February 12, 2019 | Heart Failure

His-optimized cardiac resynchronization therapy successfully narrowed QRS duration, improved left ventricular (LV) ejection fraction and heightened functionality in 27 patients with advanced heart failure (HF), according to a study…

durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
February 11, 2019 | Heart Failure

Nearly a quarter of adults living with heart failure with reduced ejection fraction (HFrEF) are prescribed at least one pharmaceutical that could exacerbate their condition, according to a study published in the…

""
February 06, 2019 | Heart Failure

Optimizing hemodynamics for heart failure (HF) patients with continuous-flow left ventricular assist devices (LVADs) significantly reduces the rate of those patients’ hospital readmissions, according to a study published Feb. 1 in…

fda-logo-large_900x550.jpg
February 05, 2019 | Heart Failure

Survival rates for patients treated with Abiomed’s Impella RP right ventricular assist device have been much lower in a postapproval study than they were during the device’s premarket clinical trials, the FDA said Feb. 4 in a…

February 01, 2019 | Heart Failure

Current conversion ratios may be underestimating the long-term cardiotoxicity of common chemotherapy agents like mitoxantrone and overestimating the cardiovascular risk of anthracyclines like daunorubicin, researchers reported in…

January 29, 2019 | Heart Failure

Knowing he needed a new heart, Robert Montgomery, MD, saw a chance to practice what he preaches. So, the 58-year-old director of NYU Langone Health’s Transplant Institute accepted an organ from a heroin user who died of a drug overdose and…

January 22, 2019 | Heart Failure

Active cocaine users with heart failure with reduced ejection fraction (HFrEF) benefited from beta-blocker therapy in a recent study, seeing improved left ventricular ejection fraction (LVEF) and reduced rates of cocaine-related CV…

home.png
January 17, 2019 | Heart Failure

The nature of caregiving means the caregiver-patient relationship is always changing, but continued support from a network of experts and dedication to mutuality and preparedness can ensure both patients and caregivers have a good …

January 14, 2019 | Cardiac Amyloidosis

Tafamidis, Pfizer’s treatment for transthyretin amyloid cardiomyopathy (ATTR-CM), has been granted a priority review designation from the FDA, potentially…

January 11, 2019 | Heart Failure

Although childhood cancer survival has improved markedly over the past few decades, a new study out of the Netherlands suggests a greater proportion of those…

January 10, 2019 | Heart Failure

A tool designed to assess the psychosocial status of heart transplant candidates may also be able to predict which left ventricular assist device (LVAD) recipients are at the highest risk of being readmitted to the hospital, Cleveland…

The National Comprehensive Cancer Network has published new patient-friendly breast cancer screening guidelines
January 10, 2019 | Heart Failure

Women with heart failure with reduced ejection fraction (HFrEF) live longer than their male counterparts, but those additional years are plagued by a lower quality of life—including greater levels of self-reported anxiety, depression and…

January 09, 2019 | Heart Failure

AI applied to an electrocardiogram (EKG) test reliably detected asymptomatic left ventricular dysfunction (ALVD)—a precursor to heart failure—and predicted which patients were most at risk of developing the condition in the future,…

January 07, 2019 | Heart Failure

A French health tech company debuted its Chronolife vest—a cotton- and lycra-based wearable aimed at preventing medical emergencies in patients with chronic or congestive heart failure (CHF)—at CES 2019 in Las Vegas on Jan. 6, CNET…

January 07, 2019 | Heart Failure

University of Chicago Medicine physicians performed the 16th and 17th triple transplant surgeries in the United States within 30 hours of each other in late December, giving two different patients a healthy heart, kidney and liver all at…

The Abbott MitraClip is the primary structural heart device used in transcatheter edge-to-edge repairs (TEER) of the mitral valve leaflets. The results of the COAPT trial dropped like a thunderclap Sunday at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, with several cardiologists predicting the MitraClip device will have a swift and lasting impact on the treatment of heart failure patients.
January 07, 2019 | Structural Heart Disease

Will operators be able to replicate COAPT’s restraint & its outcomes?

Not long after the COAPT trial for MitraClip touched off waves of applause from a rapt…

January 04, 2019 | Heart Rhythm

Compared to drug therapy alone, catheter ablation nearly halved the risk of death and improved a range of clinical outcomes for patients with both heart failure and atrial fibrillation (AFib) in a meta-analysis.

December 19, 2018 | Heart Failure

Popular anti-diabetes drug metformin could have positive implications for heart failure patients, too, according to a recent study that found the medication reduced left ventricular stiffness in mice with heart failure with preserved…

December 12, 2018 | Heart Failure

Although efforts to reduce heart failure (HF)-related deaths and readmissions in the United States were successful in the early 2000s, rates of HF-related ER visits, comorbid hospitalizations and mortality are at a standstill in 2018,…

Baboon
December 11, 2018 | Heart Failure

Two baboons recently survived for six months following the transplantation of genetically modified pig hearts, bringing scientists closer to potentially using animal organs for humans who need transplants.